Enzastaurin

( DrugBank: Enzastaurin / KEGG DRUG: Enzastaurin )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
168	エーラス・ダンロス症候群	2

168. エーラス・ダンロス症候群

臨床試験数 : 13 / 薬物数 : 21 - (DrugBank : 11) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 103

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05463679 (ClinicalTrials.gov)	January 2024	6/4/2022	Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurinfor the Prevention of Arterial Even ...	A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Enzastaurinfor the Prevention o ...	Vascular Ehlers-Danlos Syndrome	Drug: Enzastaurin;Drug: Placebo	Aytu BioPharma, Inc.	Parexel	Suspended	18 Years	60 Years	All	260	Phase 3	United States
2	EUCTR2021-006574-23-NL (EUCTR)		25/04/2022	A study to investigate the efficacy, safety, and pharmacokinetics (PK) of enzastaurinfor the prevent ...	A multicenter, randomized, double-blind, placebo-controlled study of enzastaurinfor the prevention o ...	vascular Ehlers-Danlos Syndrome (vEDS) confirmed with COL3A1 mutations MedDRA version: 20.0;Level: P ...	Product Name: Enzastaurin Product Code: AR101 INN or Proposed INN: Enzastaurin Other descriptive name: ...	Aytu BioPharma, Inc.	NULL	NA			Female: yes Male: yes	260	Phase 3	France;United States;Belgium;Netherlands;United Kingdom;Sweden

First Previous1Next Last